LH

#441
Labcorp Holdings Inc.
289.2500
+1.54%
Setor:
Base:
Moeda do lucro:
Faixa diária
288.1700
290.6499
Faixa anual
244.5200
291.6400
Mudança diária
+1.54%
Mudança mensal
+6.26%
Mudança em 6 meses
+3.63%
Mudança anual
+3.63%
Fechamento anterior
284.8650
Open
288.2300
Bid
Ask
Low
288.1700
High
290.6499
Volume
730
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization 24.0656 B
  • Employee 70 K
  • Founded 1978
  • CEO Adam H. Schechter
  • Website www.labcorp.com
  • Headquarter North Carolina, United States
  • FIGI BBG01MMT6PL7
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.98
Price to sales ratio
1.51
Dividends per share
2.88
Dividend yield %
1.15

Labcorp Holdings Inc

Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.

Notícias